China Universal Asset Management Co., Ltd. Avidity Biosciences, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 15,299 shares of RNA stock, worth $596,661. This represents 0.05% of its overall portfolio holdings.
Number of Shares
15,299
Previous 15,299
-0.0%
Holding current value
$596,661
Previous $390,000
-0.0%
% of portfolio
0.05%
Previous 0.05%
Shares
12 transactions
Others Institutions Holding RNA
# of Institutions
164Shares Held
71.6MCall Options Held
182KPut Options Held
55K-
Rtw Investments, LP New York, NY7.97MShares$311 Million3.26% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.43MShares$290 Million0.02% of portfolio
-
Black Rock Inc. New York, NY6.17MShares$240 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.83MShares$227 Million1.79% of portfolio
-
Cowen And Company, LLC5.63MShares$220 Million4.83% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $2.03B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...